Patents by Inventor Kristy L. Canavan

Kristy L. Canavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240142666
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 2, 2024
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 11953651
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: April 9, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Publication number: 20220206187
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: August 24, 2021
    Publication date: June 30, 2022
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Publication number: 20210379005
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.
    Type: Application
    Filed: August 20, 2021
    Publication date: December 9, 2021
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Patent number: 11150383
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 19, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 11096919
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 24, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Publication number: 20200222357
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.
    Type: Application
    Filed: March 26, 2020
    Publication date: July 16, 2020
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Publication number: 20190328698
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 31, 2019
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Publication number: 20190317246
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: March 6, 2019
    Publication date: October 17, 2019
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 10383839
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: August 20, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Patent number: 10267952
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: April 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Publication number: 20160282518
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: June 7, 2016
    Publication date: September 29, 2016
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 9395559
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating said ophthalmic lens with a wetting agent and packaging solution.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: July 19, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Publication number: 20150219928
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices. The ophthalmic devices are contacted with a wetting agent and heated to a temperature of at least about 50° C. to about 150° C.
    Type: Application
    Filed: April 10, 2015
    Publication date: August 6, 2015
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 9052529
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices. The ophthalmic devices are contacted with a polyamide wetting agent and heated to a temperature of at least about 50° C. to about 150° C.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 9, 2015
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Publication number: 20140185005
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: March 4, 2014
    Publication date: July 3, 2014
    Applicant: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Patent number: 8714738
    Abstract: The present invention relates to aqueous processes for the production of silicone hydrogel contact lenses.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: May 6, 2014
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Diana Zanini, James D. Ford, Shivkumar Mahadevan, Kristy L. Canavan, David C. Turner
  • Patent number: 8696115
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating said ophthalmic lens with a wetting agent and packaging solution.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: April 15, 2014
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Helene Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill, Douglas G. Vanderlaan
  • Publication number: 20130005805
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Application
    Filed: June 13, 2012
    Publication date: January 3, 2013
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Publication number: 20110021656
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: October 4, 2010
    Publication date: January 27, 2011
    Inventors: Kevin P. McCabe, Robert B. Steffen, Helene Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill, Douglas G. Vanderlaan